BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 223355)

  • 1. Bromocriptine-induced modulation of plasma aldosterone response to acute stimulations.
    Birkhäuser M; Riondel A; Vallotton MB
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):294-302. PubMed ID: 223355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic control of plasma catecholamine and aldosterone responses to acute stimuli in normal man.
    Whitfield L; Sowers JR; Tuck ML; Golub MS
    J Clin Endocrinol Metab; 1980 Oct; 51(4):724-9. PubMed ID: 6252224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man.
    degli Uberti EC; Fabbri BL; Margutti AR; Fersini CM; Pansini R
    Horm Res; 1979; 10(2-3):64-78. PubMed ID: 220171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bromocriptine treatment on the aldosterone response to angiotensin II and adrenocorticotropin in idiopathic hyperaldosteronism.
    Wisgerhof M; Mellinger RC
    J Clin Endocrinol Metab; 1985 Jul; 61(1):192-5. PubMed ID: 2987293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG; Espiner EA; Donald RA
    J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm of plasma aldosterone and time dependent alterations of aldosterone regulators.
    Takeda R; Miyamori I; Ikeda M; Koshida H; Takeda Y; Yasuhara S; Morise T; Takimoto H
    J Steroid Biochem; 1984 Jan; 20(1):321-3. PubMed ID: 6323866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of low salt plus upright posture, angiotensin II, ACTH, and potassium upon plasma renin activity, aldosterone, and cortisol (author's transl)].
    Saruta T; Kondo K; Saito I; Misumi J; Nakamura R; Kidokoro S; Matsuki S
    Nihon Naibunpi Gakkai Zasshi; 1975 Sep; 51(9):740-4. PubMed ID: 182565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bromocriptine on renin, aldosterone, and prolactin responses to posture and metoclopramide in idiopathic edema: possible therapeutic approach.
    Sowers J; Catania R; Paris J; Tuck M
    J Clin Endocrinol Metab; 1982 Mar; 54(3):510-6. PubMed ID: 7035482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of dopamine in the regulation of aldosterone and 18-hydroxycorticosterone secretion in man.
    Sowers JR; Beck FW
    J Endocrinol Invest; 1984 Oct; 7(5):473-9. PubMed ID: 6096435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of prolactin inhibition by alpha-bromoergocriptine (CB 154) on plasma aldosterone in anephric and non-nephrectomized patients on regular haemodialysis.
    Olgaard K; Hagen C; Madsen S; Hummer L
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):587-94. PubMed ID: 194447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prolonged low-dose angiotensin II infusion on the sensitivity of adrenal cortex in man.
    Oelkers W; Schöneshöfer M; Schultze G; Brown JJ; Fraser R; Morton JJ; Lever AF; Robertson JI
    Circ Res; 1975 Jun; 36(6 Suppl 1):49-56. PubMed ID: 165908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity.
    Oelkers W
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):91-7. PubMed ID: 2982239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged infusions of Ile5-angiotensin-II in sodium replete and deplete man: effects on aldosterone, ACTH, cortisol, blood pressure, and electrolyte balance.
    Oelkers W; Schöneshöfer M; Schultze G; Wenzler M; Bauer B; L'age M; Fehm HL
    J Clin Endocrinol Metab; 1978 Mar; 46(3):402-13. PubMed ID: 221518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine does not inhibit the aldosterone response to sodium depletion.
    Carey RM; Van Loon GR
    J Clin Endocrinol Metab; 1982 Jul; 55(1):162-5. PubMed ID: 7042738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of low-renin hypertension: aldosterone response to sodium restriction and upright posture, angiotensin II, ACTH and potassium in patients with hypertension.
    Saito I; Saruta T; Nakamura R; Misumi J; Kondo K; Matsuki S
    Jpn Circ J; 1976 Aug; 40(8):911-9. PubMed ID: 184308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine: lack of effect on the angiotensin II and aldosterone responses to sodium deprivation.
    Semple PF; Mason PA
    Clin Endocrinol (Oxf); 1978 Aug; 9(2):155-61. PubMed ID: 699348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic effects on kidney function and responsiveness of aldosterone, plasma renin activity, prolactin, catecholamines, and blood pressure to stimulation in patients with prolactinoma. Comparison of the efficacy of pergolide and bromocriptine therapy.
    Jungmann E; Haak T; Althoff PH; Fassbinder W; Schöffling K
    Arzneimittelforschung; 1988 Feb; 38(2):296-300. PubMed ID: 3285838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of plasma aldosterone: dependency upon basal secretory activity.
    Messerli FH; Weidmann P; DeChâtel R; Maxwell MH
    Klin Wochenschr; 1978 Jul; 56(14):719-26. PubMed ID: 209245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.